Maury Raycroft
Stock Analyst at Jefferies
(1.77)
# 3,351
Out of 5,147 analysts
59
Total ratings
33.33%
Success rate
-8.29%
Average return
Main Sectors:
Stocks Rated by Maury Raycroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYRA Tyra Biosciences | Maintains: Buy | $32 → $43 | $33.31 | +29.09% | 4 | Feb 3, 2026 | |
| DNTH Dianthus Therapeutics | Maintains: Buy | $66 → $81 | $55.19 | +46.77% | 3 | Feb 2, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $114 → $63 | $23.39 | +169.35% | 1 | Dec 30, 2025 | |
| MREO Mereo BioPharma Group | Downgrades: Hold | $7 → $0.5 | $0.37 | +34.92% | 2 | Dec 30, 2025 | |
| CELC Celcuity | Maintains: Buy | $108 → $134 | $111.71 | +19.95% | 2 | Dec 2, 2025 | |
| AUPH Aurinia Pharmaceuticals | Upgrades: Buy | $10 → $21 | $14.17 | +48.20% | 1 | Nov 7, 2025 | |
| OPK OPKO Health | Downgrades: Hold | $2 → $1.6 | $1.20 | +33.33% | 1 | Oct 31, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $550 → $549 | $332.92 | +64.90% | 4 | Oct 30, 2025 | |
| KZR Kezar Life Sciences | Downgrades: Hold | $18 → $7 | $6.70 | +4.48% | 2 | Oct 17, 2025 | |
| KOD Kodiak Sciences | Initiates: Buy | $15 | $26.80 | -44.03% | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $3.5 | $1.94 | +80.41% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $53 | $8.57 | +518.44% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $5.65 | +41.59% | 2 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $3 | $0.43 | +593.96% | 1 | Dec 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $13.66 | -56.08% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $11.14 | +70.56% | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $23 → $15 | $4.62 | +224.68% | 1 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.28 | +2,042.09% | 1 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $23 | $1.52 | +1,413.16% | 1 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $195 | $2.28 | +8,452.63% | 1 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $11 | $8.75 | +25.71% | 8 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $32 → $6 | $40.79 | -85.29% | 2 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $92 → $75 | $63.27 | +18.54% | 5 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $3.21 | +242.68% | 1 | Sep 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $38 → $5 | $1.35 | +270.37% | 2 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $11.09 | +224.62% | 1 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $105 | $6.21 | +1,590.82% | 1 | May 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $172 | $60.14 | +186.00% | 2 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $2.47 | +1,802.83% | 1 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $42 | $13.78 | +204.79% | 3 | Nov 1, 2017 |
Tyra Biosciences
Feb 3, 2026
Maintains: Buy
Price Target: $32 → $43
Current: $33.31
Upside: +29.09%
Dianthus Therapeutics
Feb 2, 2026
Maintains: Buy
Price Target: $66 → $81
Current: $55.19
Upside: +46.77%
Ultragenyx Pharmaceutical
Dec 30, 2025
Maintains: Buy
Price Target: $114 → $63
Current: $23.39
Upside: +169.35%
Mereo BioPharma Group
Dec 30, 2025
Downgrades: Hold
Price Target: $7 → $0.5
Current: $0.37
Upside: +34.92%
Celcuity
Dec 2, 2025
Maintains: Buy
Price Target: $108 → $134
Current: $111.71
Upside: +19.95%
Aurinia Pharmaceuticals
Nov 7, 2025
Upgrades: Buy
Price Target: $10 → $21
Current: $14.17
Upside: +48.20%
OPKO Health
Oct 31, 2025
Downgrades: Hold
Price Target: $2 → $1.6
Current: $1.20
Upside: +33.33%
Alnylam Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $550 → $549
Current: $332.92
Upside: +64.90%
Kezar Life Sciences
Oct 17, 2025
Downgrades: Hold
Price Target: $18 → $7
Current: $6.70
Upside: +4.48%
Kodiak Sciences
Sep 22, 2025
Initiates: Buy
Price Target: $15
Current: $26.80
Upside: -44.03%
Jun 24, 2025
Initiates: Hold
Price Target: $3.5
Current: $1.94
Upside: +80.41%
Mar 11, 2025
Maintains: Buy
Price Target: $70 → $53
Current: $8.57
Upside: +518.44%
Feb 10, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $5.65
Upside: +41.59%
Dec 31, 2024
Maintains: Buy
Price Target: $7 → $3
Current: $0.43
Upside: +593.96%
Nov 18, 2024
Initiates: Buy
Price Target: $6
Current: $13.66
Upside: -56.08%
Jul 17, 2024
Initiates: Buy
Price Target: $19
Current: $11.14
Upside: +70.56%
May 7, 2024
Assumes: Buy
Price Target: $23 → $15
Current: $4.62
Upside: +224.68%
Mar 13, 2024
Initiates: Buy
Price Target: $6
Current: $0.28
Upside: +2,042.09%
Mar 5, 2024
Initiates: Buy
Price Target: $23
Current: $1.52
Upside: +1,413.16%
Feb 8, 2024
Initiates: Buy
Price Target: $195
Current: $2.28
Upside: +8,452.63%
Aug 4, 2023
Upgrades: Buy
Price Target: $11
Current: $8.75
Upside: +25.71%
Jan 4, 2023
Downgrades: Hold
Price Target: $32 → $6
Current: $40.79
Upside: -85.29%
Nov 29, 2022
Maintains: Buy
Price Target: $92 → $75
Current: $63.27
Upside: +18.54%
Sep 12, 2022
Initiates: Buy
Price Target: $11
Current: $3.21
Upside: +242.68%
Dec 2, 2021
Downgrades: Hold
Price Target: $38 → $5
Current: $1.35
Upside: +270.37%
Jun 1, 2021
Initiates: Buy
Price Target: $36
Current: $11.09
Upside: +224.62%
May 27, 2021
Initiates: Buy
Price Target: $105
Current: $6.21
Upside: +1,590.82%
Apr 21, 2021
Upgrades: Buy
Price Target: $172
Current: $60.14
Upside: +186.00%
Feb 24, 2020
Initiates: Buy
Price Target: $47
Current: $2.47
Upside: +1,802.83%
Nov 1, 2017
Maintains: Buy
Price Target: $36 → $42
Current: $13.78
Upside: +204.79%